leisure time -WSS

leisure time

author：fashion 2025-09-02 11:46:37 - browse：2

Human embryonic stem cells Annie Cavanagh/Wellcome Images

The Food and Drug Administration on Thursday unveiled a series of guidelines that aim to encourage the development of promising and legitimate stem cell therapies while distinguishing them from the largely untested stem cell treatments hawked by unregulated clinics around the country.

The FDA’s guidelines have been expected and eagerly awaited by the stem cell community given the rapid proliferation of untested — and potentially unsafe — therapies around the country. Clinics promoting these therapies claim to be able to treat ailments from autism to neurodegenerative disorders to erectile dysfunction.

The guidelines also spell out how the agency will implement the regenerative medicine provisions in a behemoth law enacted last year called the 21st Century Cures Act.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Novo pauses ads for weight loss drug Wegovy amid demand

focus

WSS

The thinking behind the controversial eating disorder chatbot Tessa

Inside the rise of 'mukbang' eating videos

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Covid isolation guidance eased by the CDC

Obesity now affects over 1 billion people worldwide, study finds

How to fix the rural physician shortage in the U.S.

hotspot

leisure time

Wikipedia

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

An inside look at PIPEs, biotech's buzzy new financing tool

Bright Health sells Medicare Advantage business to Molina

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The thinking behind the controversial eating disorder chatbot Tessa

After affirmative action ruling, medical educators look to 'holistic review'

Biotech companies concerned about China biosecurity crackdown

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Clinical trials giant ICON acquires HumanFirst

leisure time

Biogen nominates mother of director’s child to replace him on board

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Eli Lilly’s Mounjaro succeeds in second weight

Obesity now affects over 1 billion people worldwide, study finds

International team creates first chimeric human

Pfizer highlights cancer drugs it thinks could reignite investor interest

focus

focus

focus

hotspot